/PAR
PAR
Updated 14 Oct 06:33 am
$0.245
PARADIGM BIOPHARMACEUTICALS LIMITED..
1D0.00%
1M+2.08%
1Y-37.97%
Track your position in PAR
Sign in to TradeLedgr to record trades in PAR (PARADIGM BIOPHARMACEUTICALS LIMITED..) with broker-true precision and ATO-compliant reporting.
Recent Announcements
15 Oct 2026 3:57 AM
PPS Shows Significant Pain Benefit in Rest of World Analysis1966KB
Progress Report
12 Oct 2026 4:12 AM
Expiry of PAROB Listed Options209KB
Issued Capital - Other
08 Oct 2026 6:31 AM
Notification of cessation of securities - PAR9KB
Appendix 3H (Notification of cessation of securities)
08 Oct 2026 6:24 AM
Update on Data Review and Convertible note redemption105KB
Issued Capital - Other
29 Sep 2026 11:56 PM
Continuation of Suspension from Quotation105KB
Suspension from Official Quotation
Fundamentals
P/E Ratio
—
Div Yield
0.00%
EPS
$-0.1127
Avg Vol
—
52W High
$0.470
52W Low
$0.135
Company Profile
Paradigm Biopharmaceuticals is a late-stage drug development company with the mission to develop and commercialise pentosan polysulfate sodium for the treatment of pain associated with musculoskeletal disorders driven by injury, inflammation, ageing, dege
Financial History
2026A
$-56.3M profit
$8.1M rev
2025A
$-18.8M profit
$7.1M rev
2024A
$-58.7M profit
$6.4M rev